Results 201 to 210 of about 23,309 (224)

CYP2D6 Testing

2022
openaire   +1 more source

Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites

Archives of Pharmacal Research, 2015
Jong-Hwa Jang, In Su Kim, Jung-Woo Bae
exaly  

CYP2D6 and Tamoxifen: Awaiting the Denouement

Journal of Clinical Oncology, 2011
Hiltrud B, Brauch, Werner, Schroth, James N, Ingle, Matthew P, Goetz   +3 more
openaire   +2 more sources

Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients

British Journal of Clinical Pharmacology, 2019
Espen Molden, Erik Eliasson, Marin Jukic   +2 more
exaly  

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

Journal of Clinical Pharmacology, 2010
Anne Nguyen, James Rae, Todd Skaar
exaly  

Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population

Acta Pharmacologica Sinica, 2007
Xiao Hua-Sheng, Li Hong-Mei
exaly  

A Review of the Important Role of CYP2D6 in Pharmacogenomics

Genes, 2020
Vincent Yip, Richard Turner, Munir Pirmohamed   +2 more
exaly  

Interactions of amphetamine analogs with human liver CYP2D6

Biochemical Pharmacology, 1997
, W Kalow, Werner Kalow
exaly  

Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine

Archives of Pharmacal Research, 2018
Yun Jeong Lee, Choon-Gon Jang, Seok-Yong Lee   +2 more
exaly  

CYP2D7–2D6Hybrid Tandems: Identification of Novel CYP2D6 Duplication Arrangements and Implications for Phenotype Prediction

Pharmacogenomics, 2010
J Steven Leeder, Andrea Gaedigk, Uwe Fuhr   +2 more
exaly